Free public records show Alkem Laboratories Ltd in 30 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: Wikidata, Company record Q23679985. Retrieved 13 Nov 2026.
145 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Alkem Laboratories Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Alkem Laboratories Ltd is in.
Stories on the topics Alkem Laboratories Ltd works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read